Latest Breaking News On - Meeting of the myotonic dystrophy foundation - Page 1 : comparemela.com

AMO Pharma Announces Affirming Data from REACH-CDM Clinical Trial for AMO-02 in Treatment of Myotonic Dystrophy

Results to be reviewed during 2023 Myotonic Dystrophy Annual Conference show statistically and clinically significant efficacy benefits in multipl.